Understanding how certain proteins in fat tissue affect cholesterol levels and heart disease.
Official title: Adipose MTP and FIT2 in the regulation of plasma lipids, obesity and atherosclerosis
Funded at NYU Long Island School of Medicine · NIH-11064052 · Data updated 2026-11-12
This study is looking at how two proteins, MTP and FIT2, affect fat storage and cholesterol levels, which could help us understand heart disease better, especially for people who are concerned about their heart health.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | NYU Long Island School of Medicine NIH-funded |
| Lab location | 1 site (Mineola, United States) |
| Project start | May 1, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $574,999 |
| NIH project number | 5P01HL160470-03 |
| Project ID | NIH-11064052 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for cardiovascular diseases, particularly those with high cholesterol or obesity.
✕Less likely to help
Patients who do not have issues related to lipid metabolism or cardiovascular health may not benefit from this research.
What this research studies
This research investigates the roles of two proteins, microsomal triglyceride transfer protein (MTP) and fat storage-inducing transmembrane protein 2 (FIT2), in fat tissue and their impact on cholesterol levels and heart disease. By studying mice with specific deficiencies in these proteins, the research aims to uncover how they influence fat storage, liver health, and the development of atherosclerosis. The approach includes examining the mechanisms by which these proteins affect lipid metabolism and inflammation, which are critical factors in cardiovascular health.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing and treating cardiovascular diseases by targeting lipid metabolism.
How similar studies have gone: Previous research has shown promising results in understanding lipid metabolism and its relation to cardiovascular diseases, indicating that this approach has potential for success.
Where this research is happening
-
NYU Long Island School of Medicine
Mineola, United States Active
Researchers
- Principal investigator: Hussain, M Mahmood — NYU Long Island School of Medicine
- Study coordinator: Hussain, M Mahmood
Related research
Other NIH-funded projects on the same topics.
-
Adipose MTP and FIT2: how fat tissue controls cholesterol, obesity, and heart disease
A research team at NYU Langone studies how fat tissue proteins MTP and FIT2 influence cholesterol levels, obesity, and atherosclerosis in order to find new ways to prevent heart disease.
-
How beta-carotene affects vitamin A production related to heart disease and obesity
This study is looking at how beta-carotene, a natural pigment found in foods like carrots, might help produce vitamin A and affect heart disease and obesity, using a special mouse model to see if it can reduce fat buildup and inflammation, which could lead to new treatments for these conditions.
-
Understanding how knee pain and knee obesity and muscle loss affect knee osteoarthritis
This project looks at how knee swelling, excess knee fat, and muscle loss relate to pain and structural changes in knee osteoarthritis in adults.
-
Understanding how maternal and infant sleep and daily rhythms influence early appetite and obesity risk
This project explores how infant sleep, circadian rhythms, and maternal-infant timing relate to early appetite patterns and the risk of obesity in the first year of life.
-
Coronary disease and immune activation in people with HIV and tuberculosis coinfection
This research looks at how having HIV and latent tuberculosis together might raise the risk of heart disease, and what immune changes are involved.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.